Neuron-specific enolase as a novel biomarker reflecting tuberculosis activity and treatment response |
Nam, Sung-Jin
(Department of Internal Medicine, Gyeongsang National University Changwon Hospital)
Jeong, Jee-Yeong (Department of Biochemistry, Kosin University College of Medicine) Jang, Tae-Won (Department of Internal Medicine, Kosin University College of Medicine) Jung, Mann-Hong (Department of Internal Medicine, Kosin University College of Medicine) Chun, Bong-Kwon (Department of Pathology, Kosin University College of Medicine) Cha, Hee-Jae (Department of Parasitology and Genetics, Kosin University College of Medicine) Oak, Chul-Ho (Department of Internal Medicine, Kosin University College of Medicine) |
1 | The Lancet Infectious Diseases. The deadly synergy of HIV and tuberculosis. Lancet Infect Dis 2010;10:441. DOI |
2 | Sunnetcioglu A, Sunnetcioglu M, Binici I, Baran AI, Karahocagil MK, Saydan MR. Comparative analysis of pulmonary and extrapulmonary tuberculosis of 411 cases. Ann Clin Microbiol Antimicrob 2015;14:34. DOI |
3 | Westaway MS. Useful symptom complexes in the detection of tuberculosis. S Afr Med J 1992;81:432. |
4 | American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142:725-735. DOI |
5 | Bua A, Molicotti P, Delogu G, et al. QuantiFERON TB Gold: a new method for latent tuberculosis infection. New Microbiol 2007;30:477-480. |
6 | Pai M, Joshi R, Bandyopadhyay M, et al. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection 2007;35:98-103. DOI |
7 | Johnson JL, Geldenhuys H, Thiel BA, et al. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB gold in-tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study. Chest 2014;145:612-617. DOI |
8 | Kuralay F, Tokgoz Z, Comlekci A. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin. Clin Chim Acta 2000;300:43-55. DOI |
9 | Li CS, Cheng BC, Ge W, Gao JF. Clinical value of CYFRA21-1, NSE, CA15-3, CA19-9 and CA125 assay in the elderly patients with pleural effusions. Int J Clin Pract 2007;61:444-448. DOI |
10 | Inoue S, Takahashi H, Kaneko K. The fluctuations of neuron-specific enolase (NSE) levels of cerebrospinal fluid during bacterial meningitis: the relationship between the fluctuations of NSE levels and neurological complications or outcome. Acta Paediatr Jpn 1994;36:485-488. DOI |
11 | Kang YJ, Jo JO, Ock MS, et al. Over-expression of thymosin beta4 in granulomatous lung tissue with active pulmonary tuberculosis. Tuberculosis (Edinb) 2014;94:323-331. DOI |
12 | Collazos J, Esteban C, Fernandez A, Genolla J. Measurement of the serum tumor marker neuron-specific enolase in patients with benign pulmonary diseases. Am J Respir Crit Care Med 1994;150:143-145. DOI |
13 | Song TJ, Choi YC, Lee KY, Kim WJ. Serum and cerebrospinal fluid neuron-specific enolase for diagnosis of tuberculous meningitis. Yonsei Med J 2012;53:1068-1072. DOI |
14 |
Stammet P, Collignon O, Hassager C, et al. Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at |
15 | Choi CM, Kang CI, Jeung WK, Kim DH, Lee CH, Yim JJ. Role of the C-reactive protein for the diagnosis of TB among military personnel in South Korea. Int J Tuberc Lung Dis 2007;11:233-236. |
16 | Honda K, Ohga S, Takada H, et al. Neuron-specific enolase in hemophagocytic lymphohistiocytosis: a potential indicator for macrophage activation? Int J Hematol 2000;72:55-60. |
17 |
Heitmann L, Abad Dar M, Schreiber T, et al. The IL-13/IL-4R |
18 | Lugo-Villarino G, Neyrolles O. Of clots and granulomas: platelets are new players in immunity to tuberculosis. J Infect Dis 2014;210:1687-1690. DOI |
19 | Blumberg HM, Burman WJ, Chaisson RE, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-662. DOI |
20 | Cheng VC, Yam WC, Hung IF, et al. Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol 2004;57:281-285. DOI |
21 | Heo EY, Chun EJ, Lee CH, et al. Radiographic improvement and its predictors in patients with pulmonary tuberculosis. Int J Infect Dis 2009;13:e371-376. DOI |
22 | Kang YA, Kwon SY, Yoon HI, Lee JH, Lee CT. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia. Korean J Intern Med 2009;24:337-342. DOI |
23 | Jasmer RM, Nahid P, Hopewell PC. Clinical practice: latent tuberculosis infection. N Engl J Med 2002;347:1860-1866. DOI |
24 | Koster MJ, Broekhuizen BD, Minnaard MC, et al. Diagnostic properties of C-reactive protein for detecting pneumonia in children. Respir Med 2013;107:1087-1093. DOI |
25 | Bafadhel M, Clark TW, Reid C, et al. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest 2011;139:1410-1418. DOI |
26 | Whalen CC. Diagnosis of latent tuberculosis infection: measure for measure. JAMA 2005;293:2785-2787. DOI |
27 | Lima MM, Trindade A, Carnavalli F, Bolognesi Melchior AC, Chin CM, Dos Santos JL. Tuberculosis: challenges to improve the treatment. Curr Clin Pharmacol 2015;10:242-251. DOI |
![]() |